HUMASIS CO., LTD. Logo

HUMASIS CO., LTD.

Develops & manufactures rapid in-vitro diagnostic test kits & instruments for global POCT markets.

205470 | KO

Overview

Corporate Details

ISIN(s):
KR7205470008
LEI:
Country:
South Korea
Address:
경기도 안양시 동안구 전파로 88 신원비젼타워 114호.502호.504호.604호.604-1호.비03-1호.비03-2호, 안양시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

HUMASIS CO., LTD. is a company specializing in the research, development, and manufacturing of in-vitro diagnostic (IVD) medical devices. Since its establishment in 2000, the firm has concentrated on Point-of-Care Testing (POCT) solutions, delivering rapid and accurate diagnostic results. Its product portfolio includes a wide range of immunodiagnostic rapid test kits for the early screening of conditions such as infectious diseases, cardiac markers, and tumor markers. A key aspect of its strategy is the in-house development and production of core bio-materials, such as diagnostic antigens, to ensure the quality and accuracy of its kits. The company also provides compact diagnostic instruments for quantitative analysis. Humasis serves a global market, exporting its products to numerous countries with the goal of empowering individuals through accessible self-health management tools.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-28 00:00
Legal Proceedings Report
[기재정정]소송등의제기ㆍ신청(일정금액이상의청구) (손해배상청구 등)
Korean 21.0 KB
2025-08-14 00:00
Interim Report
반기보고서 (2025.06)
Korean 1.8 MB
2025-07-28 00:00
Legal Proceedings Report
소송등의제기ㆍ신청(일정금액이상의청구) (손해배상청구 등 항소)
Korean 14.6 KB
2025-07-25 00:00
Legal Proceedings Report
기타경영사항(자율공시)
Korean 7.3 KB
2025-07-07 00:00
Legal Proceedings Report
소송등의판결ㆍ결정(일정금액이상의청구)
Korean 12.9 KB
2025-05-15 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 1.6 MB
2025-03-24 00:00
Post-Annual General Meeting Information
정기주주총회결과
Korean 18.4 KB
2025-03-18 00:00
Proxy Solicitation & Information Statement
[기재정정]의결권대리행사권유참고서류
Korean 194.6 KB
2025-03-14 00:00
Audit Report / Information
감사보고서제출
Korean 25.8 KB
2025-03-14 00:00
Audit Report / Information
사업보고서 (2024.12)
Korean 636.0 KB
2025-03-13 00:00
Proxy Solicitation & Information Statement
의결권대리행사권유참고서류
Korean 187.5 KB
2025-03-06 00:00
Pre-Annual General Meeting Information
주주총회소집결의
Korean 8.3 KB
2025-03-06 00:00
Pre-Annual General Meeting Information
주주총회소집공고
Korean 193.8 KB
2025-03-06 00:00
Proxy Solicitation & Information Statement
의결권대리행사권유참고서류
Korean 193.1 KB
2025-02-14 00:00
Earnings Release
매출액또는손익구조30%(대규모법인은15%)이상변동
Korean 11.2 KB

Automate Your Workflow. Get a real-time feed of all HUMASIS CO., LTD. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for HUMASIS CO., LTD.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for HUMASIS CO., LTD. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Active Biotech Logo
Develops immunology-based drugs for cancer and inflammatory diseases with high unmet medical need.
Sweden
ACTI
ACTUATE THERAPEUTICS, INC. Logo
Clinical-stage biopharma developing a novel GSK-3 inhibitor for hard-to-treat cancers.
United States of America
ACTU
AcuCort AB Logo
Develops a rapid oral film for acute allergies, croup, and chemo-induced nausea.
Sweden
ACUC
Acurx Pharmaceuticals, Inc. Logo
Developing a new class of antibiotics to treat priority Gram-positive bacterial infections.
United States of America
ACXP
Adagene Inc. Logo
Develops novel antibody-based immunotherapies for cancer using an AI-driven discovery platform.
United States of America
ADAG
Adaptimmune Therapeutics PLC Logo
Develops novel T-cell therapies to treat solid tumors by engineering a patient's own immune cells.
United States of America
ADAP
ADBIOTECH Co.,Ltd. Logo
Develops egg-based IgY antibodies as vaccine/antibiotic alternatives for animal and human health.
South Korea
179530
ADC Therapeutics SA Logo
Develops targeted antibody-drug conjugates for hematological and solid tumors.
United States of America
ADCT
ADIAL PHARMACEUTICALS, INC. Logo
Develops personalized, genetically-targeted drugs for treating Alcohol Use Disorder and addiction.
United States of America
ADIL
Adicet Bio, Inc. Logo
Developing off-the-shelf gamma delta T cell therapies for cancer and autoimmune diseases.
United States of America
ACET

Talk to a Data Expert

Have a question? We'll get back to you promptly.